Wednesday, April 29, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Uncertainty & Complexity

Maternal Health Disparities Post-Pandemic: Reckoning with Race, Resources, and Reform

Midyear perinatal‐mortality audits illuminate stark racial and economic gaps in maternal outcomes, galvanizing policy efforts on Medicaid expansion and doula support.

Ashley Rodgers by Ashley Rodgers
July 19, 2025
in Uncertainty & Complexity
0

A single stillbirth can unmask the fissures in our healthcare system. Midyear data from the Centers for Disease Control and Prevention reveal that perinatal mortality rates among Black and Native American mothers exceed those of White peers by more than twofold, even as overall U.S. rates crept upward in 2024 (CDC Perinatal Mortality Data). These findings have refocused attention on the ethical obligation to safeguard every mother and newborn, while igniting policy debates over the scope of Medicaid coverage and the role of doula support in closing the equity gap.

Unsettling Trends in Maternal Outcomes

Prior to the pandemic, the United States already trailed peer nations in maternal health. A 2019 report by March of Dimes noted a national maternal‐mortality ratio of 17.4 per 100,000 live births—more than double that of Canada—and persistent racial disparities, with Black women experiencing a ratio approaching 44 per 100,000 (March of Dimes Report). The pandemic exacerbated these trends: disruptions in prenatal care, heightened stressors, and resource reallocation contributed to an uptick in stillbirths and neonatal fatalities.

The CDC’s provisional 2025 figures show perinatal deaths—comprising stillbirths and early neonatal deaths—increasing from 5.8 to 6.2 per 1,000 births. Yet dissecting these numbers reveals disproportionate rises among lower‐income and minority communities. In Mississippi, the state with the nation’s highest perinatal‐mortality rate, Black mothers’ risk remained nearly three times that of White mothers in early 2025 (KFF Maternal Health).

Ethical Imperatives: Justice, Beneficence, and Autonomy

Medical ethics demands that interventions mitigate, not magnify, disparities. The principle of justice compels equitable resource distribution: every expectant mother should access high‐quality prenatal, intrapartum, and postpartum care. Beneficence obligates clinicians to advocate for interventions—such as extended Medicaid coverage and continuous labor support—that demonstrably improve outcomes. Respect for autonomy requires culturally sensitive care models that honour patient preferences, beliefs, and informed consent.

Policy Proposals: Medicaid Expansion and Doula Coverage

Two policy initiatives have gained traction:

  1. Medicaid Extension to One Year Postpartum
    Under current law, traditional Medicaid covers reproductive‐age women through sixty days postpartum. States that expanded Medicaid under the Affordable Care Act extend coverage longer, yet twenty states have not adopted expansion. The American Rescue Plan Act’s option to extend postpartum coverage to twelve months has been adopted by only 15 states as of June 2025 (CMS Postpartum Coverage). Extending full benefits would ensure continuity of care for hypertension, diabetes, and mental‐health needs that often precipitate maternal mortality long after delivery.
  2. Doula Reimbursement
    Evidence indicates that professional birth support reduces cesarean rates, preterm births, and neonatal intensive‐care admissions. A Cochrane review found that continuous labor support by doulas lowered perinatal mortality by 22 percent. Yet Medicaid covers doula services in only seven states, frequently under restrictive pilot programs (ACOG on Doulas). Advocates now press for federal mandates or incentives for universal doula reimbursement, arguing that support persons can bridge cultural and communication gaps and embody ethical principles of beneficence and respect for persons.

Individual Patient Experiences Illuminate Policy Gaps

For Ms. Lopez, a 29‐year‐old mother in rural New Mexico, losing Medicaid sixty days postpartum meant abrupt cessation of hypertension management. A subsequent hypertensive crisis forced emergency hospitalization. “I thought I’d get follow‐up, but I was told to find private insurance,” she recalls. Her narrative underscores the moral imperative to align policy with real‐world patient trajectories.

In Philadelphia, Ms. Jackson, a Black mother, credits her doula with averting a preterm birth—earning her infant a full‐term chance. Initially referred through a hospital pilot, she faced a three‐month waiting list due to limited funding. “Doulas are lifelines,” she asserts. Her experience reflects how constrained coverage undermines broad beneficence.

Structuring Equitable Solutions

To realize ethical and effective reform, stakeholders should consider:

  • Federal Incentives for State Adoption: Tie enhanced Medicaid matching funds to postpartum coverage extensions and doula reimbursement implementation.
  • Standardized Certification: Develop national doula credentialing to assure quality while minimizing bureaucratic barriers for community‐based providers.
  • Culturally Competent Training: Mandate implicit‐bias and cultural‐safety modules for all perinatal staff, fostering respect for autonomy and mitigating systemic inequities.
  • Integrated Care Models: Create perinatal medical homes that co‐locate obstetric, mental‐health, and social‐service referrals under one roof, aligning with the principle of beneficence.
  • Robust Data Systems: Enhance perinatal mortality registry granularity—capturing social determinants of health and patient‐reported outcomes—to guide targeted interventions.

Navigating Political and Financial Landscapes

Both Medicaid expansion and doula coverage confront political headwinds. Opponents cite cost concerns; the Kaiser Family Foundation estimates a 5 percent increase in state Medicaid budgets for twelve‐month postpartum coverage. Yet cost‐benefit analyses reveal that preventing a single preeclampsia emergency or NICU admission can offset expanded coverage expenditures.

Building cross‐sector coalitions—encompassing obstetricians, midwives, community advocates, and bipartisan legislators—will be crucial. In Wisconsin, the Maternal Health Task Force unites state health agencies and grassroots organizations to draft comprehensive maternal‐health legislation, signaling potential pathways for consensus.

Conclusion

The midyear perinatal‐mortality audits lay bare uncomfortable truths: racial and socioeconomic fractures in maternal health persist post‐pandemic. Addressing these gaps demands that medical ethics guide policy—ensuring justice through Medicaid reform, beneficence via doula coverage, and autonomy through culturally attuned care. As advocates strive to translate data into deliverable services, the collective commitment to safeguarding every mother and newborn will define the nation’s moral and health‐policy legacy.

ShareTweet
Ashley Rodgers

Ashley Rodgers

Ashley Rodgers is a writer specializing in health, wellness, and policy, bringing a thoughtful and evidence-based voice to critical issue

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • National Opioid Settlement Injunction

    National Opioid Settlement Injunction

    1 shares
    Share 0 Tweet 0
  • Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.

    0 shares
    Share 0 Tweet 0
  • Chronic Care Toolbox

    1 shares
    Share 0 Tweet 0
  • The Pharmacy Margin Stress Dashboard: What MedPricer’s NADAC Data Would Actually Show

    0 shares
    Share 0 Tweet 0
  • Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy